[go: up one dir, main page]

MX2009002356A - Composiciones farmaceuticas que comprenden clopidogrel. - Google Patents

Composiciones farmaceuticas que comprenden clopidogrel.

Info

Publication number
MX2009002356A
MX2009002356A MX2009002356A MX2009002356A MX2009002356A MX 2009002356 A MX2009002356 A MX 2009002356A MX 2009002356 A MX2009002356 A MX 2009002356A MX 2009002356 A MX2009002356 A MX 2009002356A MX 2009002356 A MX2009002356 A MX 2009002356A
Authority
MX
Mexico
Prior art keywords
clopidogrel
pharmaceutical formulations
melt granulate
pharmaceutically acceptable
melt
Prior art date
Application number
MX2009002356A
Other languages
English (en)
Inventor
Helene Rey
Marc Fischer
Mathias Scheer
Original Assignee
Acino Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acino Pharma Ag filed Critical Acino Pharma Ag
Publication of MX2009002356A publication Critical patent/MX2009002356A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Granulado de fundición en la forma de una dispersión en estado sólido del fármaco en un portador farmacéuticamente aceptable, en donde dicho granulado de fundición comprende un compuesto farmacéuticamente activo, preferiblemente clopidogrel, por lo menos un material portador, y opcionalmente excipientes farmacéuticamente aceptables y método de hacer dicho granulado de fundición.
MX2009002356A 2006-09-16 2007-09-17 Composiciones farmaceuticas que comprenden clopidogrel. MX2009002356A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06019429A EP1900358A1 (en) 2006-09-16 2006-09-16 Pharmaceutical formulations comprising clopidogrel
PCT/EP2007/008070 WO2008031623A1 (en) 2006-09-16 2007-09-17 Pharmaceutical formulations comprising clopidogrel

Publications (1)

Publication Number Publication Date
MX2009002356A true MX2009002356A (es) 2009-05-15

Family

ID=37735123

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009002356A MX2009002356A (es) 2006-09-16 2007-09-17 Composiciones farmaceuticas que comprenden clopidogrel.

Country Status (16)

Country Link
US (1) US20090270448A1 (es)
EP (3) EP1900358A1 (es)
AT (1) ATE552826T1 (es)
AU (1) AU2007296854A1 (es)
CA (1) CA2663311A1 (es)
DE (1) DE202007019385U1 (es)
DK (1) DK2068838T3 (es)
ES (1) ES2384740T3 (es)
IL (1) IL197089A0 (es)
MX (1) MX2009002356A (es)
NO (1) NO20091467L (es)
NZ (1) NZ575153A (es)
PL (1) PL2068838T3 (es)
PT (1) PT2068838E (es)
RU (1) RU2009114206A (es)
WO (1) WO2008031623A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1618111T3 (pl) 2003-04-25 2015-06-30 Cadila Healthcare Ltd Sole klopidogrelu i sposób wytwarzania
EP1900358A1 (en) 2006-09-16 2008-03-19 Cimex Pharma AG Pharmaceutical formulations comprising clopidogrel
CN102240269B (zh) * 2010-05-12 2013-04-10 天津泰普药品科技发展有限公司 结晶型硫酸氢氯吡格雷片剂的制备方法
WO2011160768A1 (en) * 2010-06-23 2011-12-29 Stefan Kralev Medical device for self-administration of patients with acute coronary events
CN107501289B (zh) * 2017-09-07 2019-06-14 山东齐都药业有限公司 硫酸氢氯吡格雷有关物质d的制备方法
CN110339178B (zh) * 2019-06-28 2021-07-02 广州白云山天心制药股份有限公司 一种硫酸氢氯吡格雷固体制剂的制备方法
CN115737578A (zh) * 2022-11-23 2023-03-07 石家庄四药有限公司 一种硫酸氢氯吡格雷阿司匹林复方片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530247B1 (fr) 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2623810B2 (fr) 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
US5308621A (en) * 1991-02-18 1994-05-03 Commonwealth Scientific And Industrial Research Organisation Ascorbic acid composition and transdermal administration method
JP3397385B2 (ja) * 1993-09-20 2003-04-14 第一製薬株式会社 崩壊遅延防止錠剤
CA2367373C (en) * 1999-03-17 2011-09-20 Daiichi Pharmaceutical Co., Ltd. Medicinal compositions
FR2792836B3 (fr) * 1999-04-30 2001-07-27 Sanofi Sa Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel
CA2363053C (en) 2001-11-09 2011-01-25 Bernard Charles Sherman Clopidogrel bisulfate tablet formulation
DE10305984A1 (de) * 2003-02-13 2004-09-02 Helm Ag Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen
DE10341264A1 (de) * 2003-09-04 2005-03-24 Grünenthal GmbH Schmelzformulierte, multipartikuläre orale Darreichungsform
EP1900358A1 (en) * 2006-09-16 2008-03-19 Cimex Pharma AG Pharmaceutical formulations comprising clopidogrel

Also Published As

Publication number Publication date
EP2068838B1 (en) 2012-04-11
IL197089A0 (en) 2009-11-18
ATE552826T1 (de) 2012-04-15
AU2007296854A1 (en) 2008-03-20
PT2068838E (pt) 2012-06-27
RU2009114206A (ru) 2010-10-27
WO2008031623A1 (en) 2008-03-20
CA2663311A1 (en) 2008-03-20
ES2384740T3 (es) 2012-07-11
EP2359810A2 (en) 2011-08-24
PL2068838T3 (pl) 2012-10-31
DE202007019385U1 (de) 2012-03-29
EP2068838A1 (en) 2009-06-17
DK2068838T3 (da) 2012-07-09
EP1900358A1 (en) 2008-03-19
NZ575153A (en) 2011-01-28
NO20091467L (no) 2009-04-15
US20090270448A1 (en) 2009-10-29

Similar Documents

Publication Publication Date Title
WO2008014175A3 (en) Granular pharmaceutical compositions
MX2009002356A (es) Composiciones farmaceuticas que comprenden clopidogrel.
WO2007081948A3 (en) Bioadhesive drug formulations for oral transmucosal delivery
WO2006060547A3 (en) Systems and methods for intra-oral drug delivery
IL183357A0 (en) Oral medicament for the modified release of at least one active principle, in multimicrocapsule form
MY150626A (en) Fast dissolving solid dosage form
MX2010004366A (es) Materiales inmiscibles en agua como vehiculos para suministro de farmacos.
MX2008012731A (es) Tabletas de paracetamol de liberacion rapida.
WO2007121318A3 (en) Formulations for delivering insulin
AP2012006231A0 (en) Capsule formulation of pirfenidone and pharmaceutically acceptable excipients.
PT2043600T (pt) Formulações farmacêuticas para a libertação prolongada de princípio(s) ativo(s), assim como suas aplicações, nomeadamente terapêuticas
IL191804A0 (en) Solid dispersion containing an active ingredient and tablets for oral administration containing the same
HK1208353A1 (en) Solid dosage form
WO2007144169A3 (en) Entacapone-derivatives
EP1783137A4 (en) GALACTOSIS DERIVATIVE, DRUG VECTOR AND THERAPEUTIC PREPARATION
MXPA03009391A (es) METODO PARA FABRICAR UNA COMPOSICIoN FARMACEUTICA DE DOSIS BAJA.
HRP20050371A2 (en) Administration form for pharmaceutically active peptides with sustained release and method for the production thereof
WO2008101173A3 (en) Biodegradable compositions and materials
AU2003268386A1 (en) Controlled drug release tablets
EP1731609A4 (en) INHIBITOR OF THE EXPRESSION OF RAD51, MEDICAMENT CONTAINING THE INHIBITOR AS ACTIVE INGREDIENT AND USE THEREOF
AU2003226746A1 (en) Intravaginal matrix drug delivery devices
ZA200506992B (en) Fibrate tablet and method for the production thereof
IS7383A (is) Skammtaform með stýrða lyflosun til inngjafar
ES2169980A1 (es) Microcapsulas para la liberacion prolongada de farmacos.
WO2011062936A3 (en) Self-assembled toroidal-spiral particles and manufacture and uses thereof

Legal Events

Date Code Title Description
FG Grant or registration